Medication review with follow-up for end-stage renal disease: Drug-related problems and negative outcomes associated with medication—A systematic review

A Pereira-Cespedes, A Jimenez-Morales… - Journal of Clinical …, 2023 - mdpi.com
Background: This article reviews the available scientific literature on drug-related problems
and negative outcomes associated with medications identified by medication review with …

Medication burden and prescribing patterns in patients on hemodialysis in the USA, 2013–2017

JM Paik, M Zhuo, C York, T Tsacogianis… - American journal of …, 2022 - karger.com
Introduction: The medication burden of patients with end-stage renal disease (ESRD) on
hemodialysis, a patient population with a high comorbidity burden and complex care …

Polypharmacy in chronic kidney disease: Health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy

ICO Onor, F Ahmed, AN Nguyen, MC Ezebuenyi… - The American Journal of …, 2023 - Elsevier
The rising prevalence of comorbidities in an increasingly aging population has sparked a
reciprocal rise in polypharmacy. Patients with chronic kidney disease (CKD) have a greater …

Assessment of drug utilization and potentially inappropriate medications in hemodialysis patients with end-stage renal dysfunction: A study in a tertiary care hospital in …

K Sridharan - International Journal of Risk & Safety in …, 2024 - content.iospress.com
BACKGROUND: Patients undergoing dialysis pose therapeutic challenges in terms of
polypharmacy, administration of potentially inappropriate drugs, and drugs with the potential …

Use of drugs with pharmacogenomics (PGx)‐based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis …

N Westergaard, M Baltzer Houlind… - Basic & Clinical …, 2024 - Wiley Online Library
Aim The objective of this registry study is to assess the utilization of pharmacogenomic (PGx)
drugs among patients with chronic kidney disease (CKD). Methods This study was a …

[HTML][HTML] Patients' experiences of medication management while navigating ongoing care between outpatient services: A qualitative case study of patients on …

T Zhang, M Mohsen, A Abbaticchio… - Exploratory Research in …, 2024 - Elsevier
Background Patients on hemodialysis have complex medical diagnoses and medication
regimens, requiring access to numerous health services and consultation with various …

维持性透析患者安全用药知信行现状调查及相关因素分析

魏珊, 纪鸥洋, 陈志豪, 黄泽慧, 李璞… - 上海交通大学学报 …, 2023 - xuebao.shsmu.edu.cn
目的· 调查维持性透析患者药物治疗管理过程中安全用药知识, 信念, 行为(知信行; knowledge,
attitude, belief and practice, KAP) 现状并分析其相关因素. 方法· 该研究为横断面研究 …

Fractures in CKD Patients—Risk Analysis in RRT Lombardy Patients

F Conte, DP Roggeri, MG Cozzolino, C Rossi… - Kidney and …, 2023 - mdpi.com
The increase in the number of patients with CKD starting dialysis treatment has become a
major health problem in recent years. Osteoporosis is a typical feature of advanced age …

Medicines for the Kidney

L Salama, S Sica, KE Cardone - Physician …, 2023 - physicianassistant.theclinics.com
Patients with altered kidney function have unique medication needs. Medication regimens
may require adjustments to the specific medications used, doses, or instructions, ultimately …

A prevalence study on knowledge, attitude, belief and practice of safe medication and analysis of related factors in dialysis patients

WEI Shan, JI Ouyang, C Zhihao… - Journal of Shanghai …, 2023 - xuebao.shsmu.edu.cn
Objective· To survey the status quo of knowledge, attitude, belief and practice (KAP) of safe
medication in the process of medication therapy management in dialysis patients, and …